Pelthos Therapeutics Inc. 8-K

What Happened
On May 28, 2026 Pelthos Therapeutics Inc. (PTHS) filed a Form 8-K under Regulation FD announcing that CEO Scott Plesha will present and hold one‑on‑one investor meetings at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 in New York, NY. The company furnished a press release as Exhibit 99.1 and attached its investor presentation as Exhibit 99.2. The filing notes that information on the company website is not incorporated into the 8‑K.

Key Details

• Filing date / press release: May 28, 2026.
• Speaker and activities: CEO Scott Plesha will present and participate in one‑on‑one investor meetings.
• Event: Jefferies Global Healthcare Conference, June 4, 2026, New York, NY.
• Exhibits: Press release (Exhibit 99.1) and company presentation (Exhibit 99.2) included with the 8‑K.

Why It Matters
This 8‑K notifies investors about a scheduled management presentation and makes the presentation materials publicly available. It is a Regulation FD disclosure—meant to ensure fair public access to information—rather than a report of earnings, guidance, or other financial results. Investors who want management commentary or the slides can review Exhibits 99.1 and 99.2 in the filing.